Classically, diabetic gastroparesis has been described as the slowing down of gastric motility in patients with diabetes, mainly associated with poorly controlled chronic hyperglycemia.20 Gastroparesis is defined as an abnormal delay in gastric emptying, in the absence of mechanical obstruction.21 Of the 30 to 50% of patients with longstanding diabetes, gastric emptying delay may or may not be associated with the gastrointestinal symptoms of nausea, vomiting, bloating, early satiety, and postprandial fullness.22,23 However, the presence of diabetic gastroparesis varies, according to the population analyzed and the diagnostic methods employed in each study.24 Acute dysglycemia Acute dysglycemia, i.e., acute episodes of either hyperglycemia or hypoglycemia, affect gastrointestinal motor function and intestinal sensitivity.25 Acute hyperglycemia has been associated with delayed gastric emptying or ileus.26 During episodes of diabetic ketoacidosis, 46% of patients present with abdominal pain, which, in large part, can be explained by gastric emptying delay and the electrolytic abnormalities the episodes tend to present with, such as hypokalemia
Oral semaglutide in Colleyville is an innovative GLP-1 medication developed to help patients manage weight by reducing appetite and stabilizing blood sugar levels
Microneedles in smart drug delivery
Most of our patients with chronic fatigue report improved focus, better sleep, and increased energy after glutathione treatment
These data suggest that FLX improves social and cognitive deficits, but not repetitive behavior, by suppressing hyper-glutaminergic neurotransmission and signaling by increasing 5-HT levels in the PFC of prenatal VPA mice
TB4 was confirmed to drive mobilisation, migration, and differentiation of stem and progenitor cells for tissue repair and new vessel formation, while also decreasing myofibroblast numbers in wounds resulting in reduced scar formation and fibrosis
